Agile Therapeutics, Inc.
Transdermal Delivery

Last updated:

Abstract:

Dosing regimens for transdermal delivery of hormones comprising a variable treatment cycle and a fixed rest interval are disclosed.

Status:
Application
Type:

Utility

Filling date:

13 Oct 2020

Issue date:

28 Jan 2021